Skip to main content
Livermore
Livermore
ZHEN

Personal Cfo Solutions, LLC

SEC CIK
0001677501
Latest filing
Aug 7, 2026

BCRX holding history

Biocryst Pharmaceuticals Inc in every 13F filed by Personal Cfo Solutions, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCRX overviewAll 13F holders of BCRXFull Q2 2026 holdings

Shares (Q2 2026)
21,926
Value
$219.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BCRX by Personal Cfo Solutions, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202621,926$219.3K<0.1%+259+1.2%AddedHolders
Q1 202621,667$206.3K<0.1%−40,733−65.3%ReducedHolders
Q4 202562,400$486.7K0.1%+212+0.3%AddedHolders
Q3 202562,188$472.0K0.1%00.0%UnchangedHolders
Q2 202562,188$557.2K0.1%00.0%UnchangedHolders
Q1 202562,188$466.4K0.1%+672+1.1%AddedHolders
Q4 202461,516$462.6K0.1%−215−0.3%ReducedHolders
Q3 202461,731$469.2K0.1%00.0%UnchangedHolders
Q2 202461,731$381.5K0.1%−5,000−7.5%ReducedHolders
Q1 202466,731$339.0K0.1%+428+0.6%AddedHolders
Q4 202366,303$397.2K0.1%−453−0.7%ReducedHolders
Q3 202366,756$472.6K0.1%00.0%UnchangedHolders
Q2 202366,756$470.0K0.1%−1,000−1.5%ReducedHolders
Q1 202367,756$565.1K0.1%+366+0.5%AddedHolders
Q4 202267,390$773.6K0.2%00.0%UnchangedHolders
Q3 202267,390$849.0K0.2%+302+0.5%AddedHolders
Q2 202267,088$710.0K0.2%−42,100−38.6%ReducedHolders
Q1 2022109,188$1.77M0.4%00.0%UnchangedHolders
Q4 2021109,188$1.51M0.3%00.0%UnchangedHolders
Q3 2021109,188$1.57M0.3%−2,490−2.2%ReducedHolders
Q2 2021111,678$1.77M0.4%−10,000−8.2%ReducedHolders
Q1 2021121,678$1.24M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.